A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the overall response rate in patients with
myelodysplastic syndromes (MDS) given a daily dosing schedule of decitabine.